Trial Profile
New immunosuppressive treatments to reduce the rate of recurrence of hepatocellular carcinoma after liver transplantation
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 May 2014
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Liver cancer; Transplant rejection
- Focus Therapeutic Use
- 28 May 2014 New trial record